Premas Biotech Reports Positive Preliminary Phase-1 Data for its Oral Covid-19 Vaccine, developed for Oravax Medical ...Middle East

Premas Biotech, developer of technologies & bioprocesses for novel proteins, today announced that Oravax Medical Inc., a US-based company that Premas Biotech is a shareholder in, reported positive preliminary data from its Phase 1 trial in South Africa of an oral Covid-19 vaccine candidate.

Hence then, the article about premas biotech reports positive preliminary phase 1 data for its oral covid 19 vaccine developed for oravax medical was published today ( Saturday 08/10/2022 - 08:16 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Premas Biotech Reports Positive Preliminary Phase-1 Data for its Oral Covid-19 Vaccine, developed for Oravax Medical )

Also on site :

• Group has twisted the meaning of ‘genocide’ — and hijacked a Zionist hero’s name — to suit its own woke purposes
• This Mother’s Day, don’t forget about the supermoms: grandmas
• We must stop suicidal empathy from destroying the US